Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
As of close of business last night, Banco Macro S.A. ADR’s stock clocked out at $53.15, up 3.44% from its previous closing price of $51.38. In other words, the price has increased by $3.44 from its previous closing price. On the day, 0.62 million shares were traded. BMA stock price reached its highest trading level at $53.76 during the session, while it also had its lowest trading level at $51.09.
Ratios:
To gain a deeper understanding of BMA’s stock, we examine its different ratios. In the meantime, Its Debt-to-Equity ratio is 0.23 whereas as Long-Term Debt/Eq ratio is at 0.15.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, JP Morgan on January 31, 2022, Downgraded its rating to Underweight and sets its target price to $12 from $15 previously.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BMA now has a Market Capitalization of 3815319808 and an Enterprise Value of -2641660739584. As of this moment, Banco’s Price-to-Earnings (P/E) ratio for their current fiscal year is 2.40, and their Forward P/E ratio for the next fiscal year is 4.67. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.10. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.29 while its Price-to-Book (P/B) ratio in mrq is 1.32. Its current Enterprise Value per Revenue stands at -0.929.
Stock Price History:
The Beta on a monthly basis for BMA is 1.91, which has changed by 2.0598733 over the last 52 weeks, in comparison to a change of 0.24191546 over the same period for the S&P500. Over the past 52 weeks, BMA has reached a high of $55.11, while it has fallen to a 52-week low of $14.71. The 50-Day Moving Average of the stock is 18.67%, while the 200-Day Moving Average is calculated to be 81.91%.
Shares Statistics:
It appears that BMA traded 381.88K shares on average per day over the past three months and 379520 shares per day over the past ten days. A total of 62.82M shares are outstanding, with a floating share count of 62.81M. Insiders hold about 0.02% of the company’s shares, while institutions hold 5.78% stake in the company. Shares short for BMA as of 1713139200 were 954818 with a Short Ratio of 1.96, compared to 1710460800 on 959778.
Earnings Estimates
On average, analysts expect EPS of $0 for the current quarter, with a high estimate of $0 and a low estimate of $0, while EPS last year was $1.02. The consensus estimate for the next quarter is $4.98, with high estimates of $7.94 and low estimates of $2.02.
Analysts are recommending an EPS of between $9.91 and $9.91 for the fiscal current year, implying an average EPS of $9.91. EPS for the following year is $9.13, with 2.0 analysts recommending between $11.34 and $6.92.
Revenue Estimates
A total of 2 analysts have provided revenue estimates for BMA’s current fiscal year. The highest revenue estimate was $5.64B, while the lowest revenue estimate was $266.78M, resulting in an average revenue estimate of $2.96B. In the same quarter a year ago, actual revenue was $2.33BBased on 3 analysts’ estimates, the company’s revenue will be $3.5B in the next fiscal year. The high estimate is $5.19B and the low estimate is $2.24B.
